Skip to main navigation Skip to search Skip to main content

Corrigendum to “Intracranial hemorrhage after recombinant tissue plasminogen Activator: The competing risks survival analysis” [Interdiscip. Neurosurg. 32 (2023) 101734] (Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (2023) 32, (S2214751923000178), (10.1016/j.inat.2023.101734))

  • Waitayaporn Pengtong
  • , Natnaree Aimyong
  • , Yongchai Nilanont

Research output: Contribution to journalComment/debate

Abstract

The authors regret the following correction is made on section 2. Materials and methods with underline, …“This study was approved by the Siriraj Institutional Review Board (SIRB) (COA: SI 093/2019, protocol no. 026/2562 (EC4))….” The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number102245
JournalInterdisciplinary Neurosurgery: Advanced Techniques and Case Management
Volume43
DOIs
StatePublished - Mar 2026
Externally publishedYes

Fingerprint

Dive into the research topics of 'Corrigendum to “Intracranial hemorrhage after recombinant tissue plasminogen Activator: The competing risks survival analysis” [Interdiscip. Neurosurg. 32 (2023) 101734] (Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (2023) 32, (S2214751923000178), (10.1016/j.inat.2023.101734))'. Together they form a unique fingerprint.

Cite this